Navigation Links
PROXIMATE ILS Circular Sizer Set

ProductsPROXIMATE ILS Circular Sizer Set
Company Ethicon, Inc.
Item PROXIMATE ILS Circular Sizer Set
Features 
  • Facilitates stapler size determination.
  • Used for ILS circular staplers.
  • For use in a variety of applications where an intraluminal stapler is used.
  • Set contains three sizes.
    • Description ENDOPATH ILS Circular Sizer Set for ILS circular staplers.

    The ILS Circular Sizer Set is intended to aid in selecting the appropriate size ILS Intraluminal Stapler for use in a variety of applications where an intraluminal stapler is used.
    Info Ethicon, Inc.
    Customer Service: (800) 4-ETHICON
    Web site: http://www.ethicon.com/

    Related medicine products :

    1. PROXIMATE ILS Straight Intraluminal Staplers
    2. PROXIMATE ILS Curved Intraluminal Staplers
    3. PROXIMATE Hemorrhoidal Circular Stapler (PPH Set)
    4. PROXIMATE TX Reloadable Linear Staplers
    5. PROXIMATE TL/TLH/TLV Linear Staplers
    6. PROXIMATE Access 55 Articulating Linear Staplers
    7. PROXIMATE RH Skin Stapler
    8. PROXIMATE PLUS MD Skin Stapler
    9. PROXIMATE PX Skin Stapler
    10. Circular Spine Retractor System
    11. Circular Spine Retractor
    The collection features a range of 18 Ophthalmic frames created with the most modern materials and producted to the very hightest quality. The Optical collection includes several super lightweight Ti
    The collection features a variety of colors and classic shapes, plus an array of feminine styles designed with elegant jewel detail. With styles for both men and women that are made from the same hig
    ...as put together a remarkable sunwear collection, a...ombines all of the benefits of the Titan Minimal A...th top quality sun lenses that offer 100% UV A, B ...comfortable, lightweight sun protection short of s...
    ...look of the collection has an urban twist with fas... plastic colors and rich metal tones. Design detai...enneth Cole Reaction apparel and accessory lines. ...ned with subtle top to bottom, dual-tone combinati...
    Medicine Products:
    (Date:5/10/2008)...mart to avoid devastating vision injuries, group s...) -- Every year in the United States, about 40,000...he American Academy of Ophthalmology (AAO), which ...rts-specific eye protection properly fitted by an ...arbonate materials offer the highest level of impa...
    (Date:5/9/2008)...ay 9 /PRNewswire-USNewsire/ -- U.S.,corporations p...ictims of,the Cyclone Nargis in Myanmar are relyin...rnational, to ensure that the aid will reach the p...important to remember the complete story of the hu...the people and organizations that,provide the supp...
    (Date:5/9/2008)...RNewswire-USNewswire/ -- Metaverse developer,Simua... unspeakable human,suffering in Myanmar in the wak...been developed and are being placed in high-traffi...ith coordination being arranged via the,Simuality ....com/secondlife/Simuality/106/83/41 )., In additi...
    (Date:5/9/2008)...ts a fixture of European nightlife, study says , ...teens and young adults in Europe are drinking alco...g to a survey of more than 1,300 people who are re...at a third of males and a quarter of females aged ...f sex, while cocaine, ecstasy and cannabis are use...
    Breaking Medicine News(10 mins):Health News:Protective Eyewear Key to Sports Safety 2Health News:Direct Relief's Corporate Partners Key to Aiding Cyclone Victims 2Health News:Young Adults Using Alcohol, Drugs for Better Sex 2
    ...Mostoles General Hospital Madrid, had pointed out ...sponsible for increased risk of dementia. Essentia... a kind of movement disorder. Involuntary movement...the hands, head, neck, face etc. It affects few pe...
    ...versity of Michigan had pointed out that despite o...disparity when it comes to providing healthcare to... tests done for patients with stroke due to ischem...heart, brain MRI, ultrasound of the carotid artery...
    ... conditions like seasonal affective disorder (SAD...ists of University of North Carolina. Researchers...t the mood disorder diagnosis. Treatment was based...ight treatment for non-seasonal depressions and co...
    ...at herbal preparations and over the counter altern... with medication for rheumatic arthritis. The stud...e medicines are widely used by people suffering fr... preparations are exempted from the government reg...
    Other Medicine News:
    (Date:5/9/2008)... Fla., May 9 /PRNewswire-USNewswire/ -- Many stron...ects. These can include nausea and,vomiting with s...ic use.,Such symptoms can lead patients to discont... pain management for physicians. The novel investi... oral analgesic, provided pain,relief for patients...
    (Date:5/9/2008)...Cytopia,s development of early pipeline cancer dru...wire-FirstCall/ -- Cytopia Limited,(ASX: CYT) toda...r drug,discovery and development collaboration wit...leverages Cytopia,s early stage drug discovery pip...erapeutics that is one of the,fastest growing segm...
    (Date:5/8/2008)... May 8 /- Globus Medical, Inc., the l...in the world and a recognized,leader in motion pre...on of,enrollment in its SECURE(R)-C Cervical Artif...signed to mimic the normal motion of the spine in,... alternative to fusion in,the treatment of symptom...
    (Date:5/8/2008)... Fla., May 8 /- Alpharma In...l company, today announced results from,clinical t...lfate,extended-release with sequestered naltrexone...elevant features addressing abuse liability,alongs...hase I and II,studies, presented at the 27th Annua...
    Breaking Medicine Technology:New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4Cytopia Announces Novel Anti-Cancer Drug Development Collaboration 2Cytopia Announces Novel Anti-Cancer Drug Development Collaboration 3Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7VMware Desktop Virtualization Helps Healthcare Providers Improve Patient Care 11111 1VMware Desktop Virtualization Helps Healthcare Providers Improve Patient Care 11111 2VMware Desktop Virtualization Helps Healthcare Providers Improve Patient Care 11111 3VMware Desktop Virtualization Helps Healthcare Providers Improve Patient Care 11111 4VMware Desktop Virtualization Helps Healthcare Providers Improve Patient Care 11111 5VMware Desktop Virtualization Helps Healthcare Providers Improve Patient Care 11111 6NuView Radiopharmaceuticals Inc Secures Exclusive Rights From Thomas Jefferson University for a Tumor Specific Imaging Agent for the Diagnosis of Br 11107 1NuView Radiopharmaceuticals Inc Secures Exclusive Rights From Thomas Jefferson University for a Tumor Specific Imaging Agent for the Diagnosis of Br 11107 2NuView Radiopharmaceuticals Inc Secures Exclusive Rights From Thomas Jefferson University for a Tumor Specific Imaging Agent for the Diagnosis of Br 11107 3Arena Pharmaceuticals to Present at the BIO CEO 26 Investor Conference 3062 1Arena Pharmaceuticals to Present at the BIO CEO 26 Investor Conference 3062 2Arena Pharmaceuticals to Present at the BIO CEO 26 Investor Conference 3062 3Rigel to Present at BIO CEO 26 Investor Conference 3058 1
    ...udy results also show evidence of additional prote...virus types, LOS ANGELES, April 17, 2007 /PRNewswi...er candidate vaccine, CERVARIX(R),demonstrated 10...ons due to cancer-causing human papillomavirus typ...llow-up trial, according to,data presented today a...
    ...M, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Adnexus(...ation of the abstract,"CT-322: A specific VEGFR-2-...n preclinical tumor models comparable to pan-speci...and sorafenib" at the,American Association for Can...eles, CA. The lead author is Irvith Carvajal, Ph.D...
    Other Medicine Technology:Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 2Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 3Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 4Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100,Percent Protection Against Precancerous Lesions Caused By,Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than,Five Years 5Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 2Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 3Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 4